YourCompanyListing.com

INDIANAPOLIS, July 23 /PRNewswire/ -- BioStorage Technologies, Inc.
(BST) will serve as the biorepository partner for the first phase of the
Indiana Health Study, a new landmark longitudinal study of coronary artery
disease. This community-based research initiative will utilize the
population of Indianapolis and surrounding areas as study participants and
will enable research that will lead to new drugs and diagnostics that allow
doctors to better manage common, chronic diseases such as heart disease,
cancer and diabetes.

    Sponsored by the Fairbanks Institute for Healthy Communities, an
Indianapolis-based nonprofit organization, the Indiana Health Study will
create one of the nation's most comprehensive resources for academic and
commercial research by integrating biological samples, medical data and
lifestyle information collected from two cohorts of people: patients with
coronary artery disease and people without the disease.

    The collected biological samples will be stored at BST's
state-of-the-art facility located in Indianapolis. "We selected BioStorage
because of their expertise in cold chain logistics, sample management and
long term storage, which are all necessities for a study of this scope and
importance," said Dr. Cynthia Helphingstine, president and COO of the
Fairbanks Institute. "We are fortunate to have partnered with a company
that shares our strong commitment for community-based life science
research."

    Dr. John F. Mills, M.D., Ph.D., chief executive officer of BioStorage
Technologies believes the Indiana Health Study can make a significant
impact on the future of health care for people in Indiana and around the
world. "We believe we can play a vital role in advancing health care and
research initiatives through ensuring sample integrity. In a study of this
magnitude samples are vital and could possibly hold the key to unlocking
the causes of some of this nation's deadliest diseases."

    While the Indiana Health Study will follow participants for years,
Helphingstine anticipates immediate benefits as well. Samples will be
available for researchers as soon as they are collected. The Fairbanks
Institute intends to study multiple chronic diseases with future research
platforms including studies on cancer, diabetes and central nervous system
disorders.

    About BioStorage Technologies, Inc.:

    BioStorage Technologies, Inc. is a leader in sample storage, inventory
management and coldchain logistics for the biotechnology and pharmaceutical
industries. The company offers secure, temperature-controlled storage;
real-time tracking of stored biological samples; and next-day return of
biomaterials. BioStorage Technologies is privately-held and headquartered
in Indianapolis with an additional full-service site near Frankfurt,
Germany. For more information, visit http://www.biostorage.com or call +1 (866)
697-2675 or +49-6155-898-1010.

    About Fairbanks Institute

    Formed with a $10 million gift from the Richard M. Fairbanks Foundation
and the collaboration of BioCrossroads, Indiana University School of
Medicine, Regenstrief Institute and other Indianapolis community health
leaders, Fairbanks Institute is creating one of the nation's most
comprehensive resources for finding better ways to prevent, diagnose and
treat the nation's most common, chronic diseases.



    Press Contact:
    Whitney Dean
    Miller Brooks, Inc.
    317-873-8100
    whitney@millerbrooks.com